Nasdaq: COGT

Cogent Biosciences, Inc. (COGT)

Cogent Biosciences, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker COGT. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
COGT
Exchange
Nasdaq
SEC CIK
1622229
Official filings
SEC EDGAR

Research COGT

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Cogent Biosciences, Inc.'s stock ticker?

Cogent Biosciences, Inc. trades under the ticker symbol COGT on Nasdaq. Its SEC Central Index Key (CIK) is 1622229.

Where can I read Cogent Biosciences, Inc.'s SEC filings?

The COGT SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Cogent Biosciences, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze COGT's financial statements?

The COGT Financials page shows Cogent Biosciences, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does COGT compare with its peers and the market?

The COGT Peer Comparison page lines Cogent Biosciences, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.